Another US Humira Biosimilar Approved As Formularies Offer Access

While Alvotech And Stada Broaden Reach Of Higher-Strength Adalimumab In Europe

 
• By Dave Wallace
  
Fresenius Kabi logo on building
Fresenius Kabi has received US approval for its Idacio biosimilar • Source: Shutterstock

More from Products

More from Generics Bulletin